We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

74 hedge funds and large institutions have $485M invested in Orchard Therapeutics plc American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9% less funds holding

Funds holding: 81 → 74 (-7)

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

46% less capital invested

Capital invested by funds: $895M → $485M (-$410M)

Holders
74
Holders Change
-7
Holders Change %
-8.64%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
26
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$45.8M
2
VC
Vivo Capital
California
+$18.7M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$11.1M
4
WP
Woodline Partners
California
+$5.51M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.14M

Top Sellers

Rank Fund Capital Flow
1
ECM
Element Capital Management
New York
-$13.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$12.8M
3
JP Morgan Chase
JP Morgan Chase
New York
-$11.9M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$9.79M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
26
Polar Capital
United Kingdom
$2.64M – – –
EAM
27
Eventide Asset Management
Massachusetts
$2.03M – – –
Victory Capital Management
28
Victory Capital Management
Texas
$1.95M +$1.41M +12,211 +90%
Renaissance Technologies
29
Renaissance Technologies
New York
$1.94M +$2.69M +23,350 +985%
CAM
30
Cormorant Asset Management
Massachusetts
$1.93M -$1.08M -9,355 -27%
GTC
31
Ghost Tree Capital
New York
$1.34M -$533K -4,625 -21%
AA
32
ALPS Advisors
Colorado
$1.3M -$214K -1,861 -10%
Bank of America
33
Bank of America
North Carolina
$1.08M +$173K +1,505 +12%
PIM
34
Platinum Investment Management
Australia
$1.04M +$1.6M +13,883 New
BL
35
Bleichroeder LP
New York
$943K +$1.44M +12,520 New
N
36
Nuveen
North Carolina
$895K -$429K -3,728 -24%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$681K -$324K -2,810 -24%
PPA
38
Parametric Portfolio Associates
Washington
$679K +$73.8K +641 +8%
MOACM
39
Mutual of America Capital Management
New York
$581K -$39K -339 -4%
State Street
40
State Street
Massachusetts
$572K +$406K +3,525 +87%
Goldman Sachs
41
Goldman Sachs
New York
$457K +$416K +3,609 +147%
Two Sigma Investments
42
Two Sigma Investments
New York
$399K +$361K +3,133 +144%
Neuberger Berman Group
43
Neuberger Berman Group
New York
$301K – – –
SEI Investments
44
SEI Investments
Pennsylvania
$299K +$457K +3,971 New
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$289K +$274K +2,377 +163%
MC
46
Matisse Capital
Oregon
$288K +$14.7K +128 +3%
Northern Trust
47
Northern Trust
Illinois
$284K -$21K -182 -5%
Canada Pension Plan Investment Board
48
Canada Pension Plan Investment Board
Ontario, Canada
$223K -$871K -7,561 -72%
VEA
49
Virtus ETF Advisers
New York
$219K -$49.1K -426 -13%
Two Sigma Advisers
50
Two Sigma Advisers
New York
$173K +$265K +2,300 New
1
2
3 4

ORTX Hedge Fund Activity: Q1 2020 in Review

74 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q1 2020, worth a combined $485M — down 46% from $895M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of ORTX and 13 opened new positions — a net loss of 6 holders — while 22 trimmed existing stakes and 26 added.

The largest buyer was RA Capital Management, adding an estimated $45.8M. The largest seller was Element Capital Management, exiting entirely with an estimated $13.4M sold.

  • 74 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q1 2020, down from 81 in Q4 2019.
  • Funds reported $485M of Orchard Therapeutics plc American Depositary Shares stock for Q1 2020, down 46% quarter-over-quarter.
  • 13 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q1 2020 and 19 closed out, a net change of -6 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q1 2020 was RA Capital Management, an estimated $45.8M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q1 2020 was Element Capital Management, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2020.